Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Given the data presented here, further investigation of the effects of long-acting risperidone in these particular patient groups is warranted.

Authors

Institutions

Publication Details

Journal
Psychopharmacology Bulletin
Published
2025-08-12
DOI
https://doi.org/10.64719/pb.4123
Citations
14
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
1.47
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Eduard Parellada
14 citations
Psychopharmacology Bulletin
Schizophrenia research and treatment
1.47
article

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Eduard Parellada
article en
14 citations

Abstract

Given the data presented here, further investigation of the effects of long-acting risperidone in these particular patient groups is warranted.

Psychopharmacology BulletinVol. 40(2)
Neurosciences Institute (US), Hospital Clínic de Barcelona (ES)
No poverty
Openalex Percentile: Top 24%
Schizophrenia research and treatment
1.47
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations — Eduard Parellada · Psychopharmacology Bulletin (2025) | TGRS Research Map | TGRS